Filing Details

Accession Number:
0001104659-22-063797
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-23 14:45:54
Reporting Period:
2022-05-12
Accepted Time:
2022-05-23 14:45:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563665 Biostage Inc. BSTG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008643 David Green C/O Biostage, Inc.
84 October Hill Road, Suite 11
Holliston MA 01746
Interim Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-12 63,345 $5.92 158,861 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2022-05-12 31,673 $0.00 31,673 $8.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,673 2022-05-12 2027-05-12 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,468 Indirect 2018 Biostage GRAT
Footnotes
  1. On May 12, 2022, the Issuer and the Reporting Person entered into 2 securities purchase agreements (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 63,345 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 31,673 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreements was $375,000.